Raporty finansowe: Rachunek zysków i strat
BAY (BAYER)
88.00+0.63(+0.72%)
BAYER AG
TENDENCJE POZYTYWNE
Zysk operacyjny (EBIT): wzrost o 88.00% r/r |
Zysk przed opodatkowaniem: wzrost o 47.61% r/r |
Zysk netto: wzrost o 52.21% r/r |
TENDENCJE NEGATYWNE
Przychody ze sprzedaży: spadek o 10.01% r/r |
Zysk ze sprzedaży: spadek o 38.53% r/r |
EBITDA: spadek o 21.27% r/r |
2011/Q3 (wrz 11) | 2012/Q3 (wrz 12) | 2013/Q3 (wrz 13) | 2014/Q3 (wrz 14) | 2015/Q3 (wrz 15) | 2016/Q3 (wrz 16) | 2017/Q3 (wrz 17) | 2018/Q3 (wrz 18) | 2019/Q3 (wrz 19) | 2020/Q3 (wrz 20) | 2021/Q3 (wrz 21) | 2022/Q3 (wrz 22) | 2023/Q3 (wrz 23) | 2024/Q3 (wrz 24) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Data publikacji | 2011-10-27 | 2012-10-30 | 2013-10-31 | 2014-10-30 | 2015-10-29 | 2016-10-26 | 2017-10-26 | 2018-11-13 | 2019-10-30 | 2020-11-03 | 2021-11-09 | 2022-11-08 | 2023-11-08 | 2024-11-12 | |
Przychody ze sprzedaży | 120 588 974 k/k +62.04% | 122 994 392 r/r +1.99% k/k +42.75% | 127 623 185 r/r +3.76% k/k +42.92% | 130 275 600 r/r +2.08% k/k +52.14% | 148 372 193 r/r +13.89% k/k +47.58% | 150 700 088 r/r +1.57% k/k +43.76% | 113 842 113 r/r -24.46% k/k +5.89% | 121 837 414 r/r +7.02% k/k +50.03% | 143 432 212 r/r +17.72% k/k +37.69% | 142 164 154 r/r -0.88% k/k +39.01% | 152 714 283 r/r +7.42% k/k +45.72% | 188 651 182 r/r +23.53% k/k +46.79% | 165 838 590 r/r -12.09% k/k +46.52% | 149 242 171 r/r -10.01% k/k +38.92% | |
Techniczny koszt wytworzenia produkcji sprzedanej | 58 373 410 k/k +63.51% | 58 740 950 r/r +0.63% k/k +43.65% | 60 849 642 r/r +3.59% k/k +44.29% | 61 956 069 r/r +1.82% k/k +53.11% | 66 732 518 r/r +7.71% k/k +47.48% | 64 248 800 r/r -3.72% k/k +44.14% | 35 916 349 r/r -44.10% k/k -18.79% | 46 677 859 r/r +29.96% k/k +66.67% | 55 072 371 r/r +17.98% k/k +34.15% | 70 025 069 r/r +27.15% k/k +80.77% | 60 834 610 r/r -13.12% k/k +45.57% | 73 548 589 r/r +20.90% k/k +44.74% | 70 753 163 r/r -3.80% k/k +52.12% | 66 527 168 r/r -5.97% k/k +47.51% | |
Koszty sprzedaży | 28 721 323 k/k +64.60% | 29 964 919 r/r +4.33% k/k +46.22% | 32 815 463 r/r +9.51% k/k +48.37% | 32 339 248 r/r -1.45% k/k +57.97% | 38 249 126 r/r +18.27% k/k +49.57% | 38 536 344 r/r +0.75% k/k +45.62% | 34 653 782 r/r -10.08% k/k +32.50% | 35 999 359 r/r +3.88% k/k +51.47% | 40 543 272 r/r +12.62% k/k +45.62% | 46 291 057 r/r +14.18% k/k +74.79% | 41 038 228 r/r -11.35% k/k +55.36% | 50 538 784 r/r +23.15% k/k +53.81% | 44 701 091 r/r -11.55% k/k +52.42% | 41 785 412 r/r -6.52% k/k +46.64% | |
Koszty ogólnego zarządu | 15 037 781 k/k +62.94% | 14 723 290 r/r -2.09% k/k +46.34% | 15 427 442 r/r +4.78% k/k +47.32% | 15 850 198 r/r +2.74% k/k +53.11% | 19 298 346 r/r +21.75% k/k +53.21% | 21 232 288 r/r +10.02% k/k +49.23% | 20 287 243 r/r -4.45% k/k +37.03% | 22 770 833 r/r +12.24% k/k +58.16% | 29 626 766 r/r +30.11% k/k +44.83% | 36 440 740 r/r +23.00% k/k +101.37% | 30 465 950 r/r -16.40% k/k +58.16% | 34 458 705 r/r +13.11% k/k +54.05% | 27 808 964 r/r -19.30% k/k +58.36% | 7 864 986 r/r -71.72% k/k +43.47% | |
Zysk ze sprzedaży | 18 456 461 k/k +53.30% | 19 565 233 r/r +6.01% k/k +32.93% | 18 530 639 r/r -5.29% k/k +27.51% | 20 130 086 r/r +8.63% k/k +40.35% | 24 092 202 r/r +19.68% k/k +40.75% | 26 682 656 r/r +10.75% k/k +36.41% | 22 984 739 r/r -13.86% k/k +2.96% | 16 389 362 r/r -28.69% k/k +8.98% | 18 189 802 r/r +10.99% k/k +22.72% | -10 592 712 r/r -158.23% k/k -155.90% | 20 375 494 r/r +292.35% k/k +17.55% | 30 105 104 r/r +47.75% k/k +33.91% | 22 575 372 r/r -25.01% k/k +14.10% | 13 877 121 r/r -38.53% k/k -11.82% | |
Pozostałe przychody operacyjne | 2 527 618 k/k +31.81% | 1 933 486 r/r -23.51% k/k +59.20% | 2 757 460 r/r +42.62% k/k +39.99% | 1 724 482 r/r -37.46% k/k +99.25% | 2 712 704 r/r +57.31% k/k +132.64% | 2 436 280 r/r -10.19% k/k +52.07% | 2 710 424 r/r +11.25% k/k +43.79% | 19 451 956 r/r +617.67% k/k +1223.39% | 5 169 595 r/r -73.42% k/k +153.29% | 5 803 358 r/r +12.26% k/k +79.98% | 5 559 480 r/r -4.20% k/k +38.64% | 7 699 154 r/r +38.49% k/k +27.61% | 5 117 702 r/r -33.53% k/k +15.23% | 4 788 313 r/r -6.44% k/k +40.18% | |
Pozostałe koszty operacyjne | 5 456 654 k/k +26.74% | 8 231 714 r/r +50.86% k/k +41.21% | 3 246 551 r/r -60.56% k/k -0.54% | 1 206 720 r/r -62.83% k/k +87.11% | 4 162 305 r/r +244.93% k/k +70.51% | 2 156 000 r/r -48.20% k/k +50.36% | 2 951 734 r/r +36.91% k/k +51.49% | 1 311 320 r/r -55.57% k/k +142.46% | 6 770 333 r/r +416.30% k/k +46.08% | 75 262 577 r/r +1011.65% k/k +27.19% | 19 763 951 r/r -73.74% k/k +11.55% | 10 630 773 r/r -46.21% k/k +32.74% | 35 003 416 r/r +229.26% k/k +129.51% | 19 542 650 r/r -44.17% k/k +449.89% | |
Zysk operacyjny (EBIT) | 15 527 424 k/k +60.88% | 13 267 005 r/r -14.56% k/k +31.31% | 18 041 548 r/r +35.99% k/k +36.28% | 20 647 848 r/r +14.45% k/k +41.78% | 22 642 601 r/r +9.66% k/k +42.93% | 26 962 936 r/r +19.08% k/k +36.67% | 22 743 430 r/r -15.65% k/k +2.17% | 34 529 998 r/r +51.82% k/k +116.25% | 16 589 065 r/r -51.96% k/k +35.66% | -80 051 931 r/r -582.56% k/k -116.35% | 6 171 023 r/r +107.71% k/k +70.20% | 27 173 484 r/r +340.34% k/k +32.52% | -7 310 341 r/r -126.90% k/k -181.44% | -877 216 r/r +88.00% k/k -105.62% | |
Przychody finansowe | 1 707 134 k/k +83.00% | 1 312 302 r/r -23.13% k/k +25.70% | 906 505 r/r -30.92% k/k +26.14% | 1 077 279 r/r +18.84% k/k +36.27% | 546 779 r/r -49.24% k/k +34.39% | 487 256 r/r -10.89% k/k +39.37% | 930 766 r/r +91.02% k/k +61.93% | 2 921 638 r/r +213.90% k/k +26.39% | 1 368 937 r/r -53.14% k/k +35.27% | 2 150 230 r/r +57.07% k/k +501.83% | 1 848 527 r/r -14.03% k/k +10.81% | 964 220 r/r -47.84% k/k +76.07% | 1 631 731 r/r +69.23% k/k +72.95% | 1 741 594 r/r +6.73% k/k +57.73% | |
Koszty finansowe | 4 243 574 k/k +78.30% | 3 430 909 r/r -19.15% k/k +26.99% | 3 566 990 r/r +3.97% k/k +43.79% | 3 678 616 r/r +3.13% k/k +72.00% | 4 094 488 r/r +11.31% k/k +48.36% | 4 307 688 r/r +5.21% k/k +39.65% | 5 446 702 r/r +26.44% k/k +48.81% | 6 988 010 r/r +28.30% k/k +95.39% | 6 206 138 r/r -11.19% k/k +46.84% | 6 088 546 r/r -1.89% k/k +38.55% | 5 689 201 r/r -6.56% k/k +40.61% | 9 140 615 r/r +60.67% k/k +57.49% | 8 900 352 r/r -2.63% k/k +79.37% | 8 442 664 r/r -5.14% k/k +47.18% | |
Pozostałe przychody (koszty) | -145 570 k/k -73.88% | -148 097 r/r -1.74% k/k -215.94% | -50 596 r/r +65.84% k/k -46.09% | -45 931 r/r +9.22% k/k -37.98% | -16 954 r/r +63.09% | -73 304 r/r -332.36% k/k -50.58% | -86 182 r/r -17.57% k/k +15.04% | 350 255 r/r +506.41% k/k -18.06% | 765 380 r/r +118.52% k/k +586.50% | -307 822 r/r -140.22% k/k -187.19% | 213 113 r/r +169.23% k/k -40.33% | -491 850 r/r -330.79% k/k -78.11% | -556 272 r/r -13.10% k/k -52.43% | -350 886 r/r +36.92% k/k -66.03% | |
Zysk z działalności gospodarczej | 12 845 414 k/k +58.18% | 11 000 301 r/r -14.36% k/k +30.97% | 15 330 467 r/r +39.36% k/k +33.98% | 18 000 581 r/r +17.42% k/k +36.56% | 19 077 939 r/r +5.99% k/k +41.43% | 23 069 200 r/r +20.92% k/k +36.14% | 18 141 311 r/r -21.36% k/k -4.89% | 30 813 880 r/r +69.85% k/k +103.66% | 12 517 243 r/r -59.38% k/k +41.33% | -84 298 070 r/r -773.46% k/k -104.88% | 2 543 462 r/r +103.02% k/k +58.48% | 18 505 240 r/r +627.56% k/k +23.59% | -15 135 234 r/r -181.79% k/k -429.55% | -7 929 172 r/r +47.61% k/k -173.71% | |
Wynik zdarzeń nadzwyczajnych | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Zysk przed opodatkowaniem | 12 845 414 k/k +58.18% | 11 000 301 r/r -14.36% k/k +30.97% | 15 330 467 r/r +39.36% k/k +33.98% | 18 000 581 r/r +17.42% k/k +36.56% | 19 077 939 r/r +5.99% k/k +41.43% | 23 069 200 r/r +20.92% k/k +36.14% | 18 141 311 r/r -21.36% k/k -4.89% | 30 813 880 r/r +69.85% k/k +103.66% | 12 517 243 r/r -59.38% k/k +41.33% | -84 298 070 r/r -773.46% k/k -104.88% | 2 543 462 r/r +103.02% k/k +58.48% | 18 505 240 r/r +627.56% k/k +23.59% | -15 135 234 r/r -181.79% k/k -429.55% | -7 929 172 r/r +47.61% k/k -173.71% | |
Zysk (strata) netto z działalności zaniechanej | 0 | 0 | 0 | 367 444 k/k +40.17% | 330 611 r/r -10.02% k/k +27.13% | 771 848 r/r +133.46% k/k +64.54% | 19 942 515 r/r +2483.74% k/k +1810.30% | 59 800 r/r -99.70% k/k +128.51% | 997 181 r/r +1567.54% | 23 308 493 r/r +2237.44% k/k +2632.51% | 0 r/r -100.00% | 0 | 0 | 0 | |
Zysk netto | 9 153 240 k/k +60.67% | 8 573 159 r/r -6.34% k/k +31.75% | 11 569 527 r/r +34.95% k/k +33.22% | 13 415 882 r/r +15.96% k/k +35.47% | 14 898 679 r/r +11.05% k/k +43.98% | 18 623 528 r/r +25.00% k/k +38.93% | 34 231 490 r/r +83.81% k/k +116.10% | 24 146 224 r/r -29.46% k/k +100.66% | 11 743 116 r/r -51.37% k/k +67.79% | -48 880 386 r/r -516.25% k/k -35.95% | -685 669 r/r +98.60% k/k +36.27% | 17 321 879 r/r +2626.27% k/k +23.15% | -19 858 910 r/r -214.65% k/k -1623.00% | -9 491 044 r/r +52.21% k/k -211.36% | |
Zysk netto akcjonariuszy jednostki dominującej | 9 144 418 k/k +60.29% | 8 523 794 r/r -6.79% k/k +31.51% | 11 527 364 r/r +35.24% k/k +33.07% | 13 369 951 r/r +15.98% k/k +35.24% | 14 822 384 r/r +10.86% k/k +43.95% | 17 584 336 r/r +18.63% k/k +37.44% | 30 973 811 r/r +76.14% k/k +121.61% | 24 086 425 r/r -22.24% k/k +100.60% | 11 708 127 r/r -51.39% k/k +67.39% | -48 903 020 r/r -517.68% k/k -35.87% | -745 897 r/r +98.47% k/k +32.93% | 17 234 222 r/r +2410.54% k/k +23.02% | -19 831 097 r/r -215.07% k/k -1631.31% | -9 486 765 r/r +52.16% k/k -211.88% | |
EBITDA | 24 274 834 k/k +61.43% | 22 708 176 r/r -6.45% k/k +35.39% | 26 971 671 r/r +18.78% k/k +38.39% | 29 136 639 r/r +8.03% k/k +44.53% | 32 713 515 r/r +12.28% k/k +44.62% | 38 251 752 r/r +16.93% k/k +36.96% | 30 607 537 r/r -19.98% k/k +6.05% | 43 431 595 r/r +41.90% k/k +105.95% | 33 029 427 r/r -23.95% k/k +38.12% | -22 335 231 r/r -167.62% k/k +14.19% | 21 672 706 r/r +197.03% k/k +46.25% | 49 861 882 r/r +130.07% k/k +34.12% | 37 019 902 r/r -25.76% k/k +25.11% | 29 144 950 r/r -21.27% k/k +15.08% |
Dane kwartalne RZiS oraz CashFlow obliczne są na podstawie publikowanych danych skumulowanych.
Dynamika zmian dla sektora obliczana jest w oparciu o medianę.
Dane w tys. PLN
Informacje
ISIN: | DE000BAY0017 |
---|---|
Liczba akcji: | 826 950 000 |
Kapitalizacja: | 72 771 600 000 |
Enterprise Value: | 229 142 751 300 |
Branża: | Produkcja leków |
Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals... Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals koncentruje się na badaniach, opracowywaniu i sprzedaży produktów na receptę i specjalistycznych terapii, szczególnie w dziedzinie kardiologii, onkologii, ginekologii, hematologii i okulistyki, a także radiofarmakologii i innych. Segment Consumer Health opracowuje, produkuje i sprzedaje bez recepty produkty dostępne bez recepty w zakresie m.in. dermatologii, suplementów diety, leków przeciwbólowych, przewodu pokarmowego, przeziębienia, alergii, zatok i grypy, pielęgnacji stóp i ochrony przeciwsłonecznej. Segment Crop Science bada, rozwija i wprowadza na rynek rozwiązania i nasiona do ochrony roślin, a także obejmuje spółkę zależną Monsanto. Segment Animal Health zajmuje się opracowywaniem, produkcją i marketingiem weterynaryjnych produktów na receptę i bez recepty.
Nazwa: | BAYER AG |
---|---|
Adres: | Werk Leverkusen, 51-368, Leverkusen, Deutschland |
CEO: | Bill Anderson |
Telefon: | +49 (0) 214 30-1 |
WWW: | http://www.bayer.com/ |